OnabotulinumtoxinA

OnabotulinumtoxinA May Be Safe, Effective for Long-Term Headache Prevention in Chronic Migraine

OnabotulinumtoxinA May Be Safe, Effective for Long-Term Headache Prevention in Chronic Migraine

By

The use of onabotulinumtoxinA every 12 weeks over a 2-year period was found to be safe, and effective for headache prevention in patients with chronic migraine.

OnabotulinumtoxinA for Tension-Type Headache: Research vs Real-Life Settings

OnabotulinumtoxinA for Tension-Type Headache: Research vs Real-Life Settings

By

Despite its prevalence, tension-type headache is often complicated by overlapping symptoms and a weak understanding of tension-type headache etiology.

Factors Contributing to Improved Outcomes With OnabotulinumtoxinA for Chronic Migraine

Factors Contributing to Improved Outcomes With OnabotulinumtoxinA for Chronic Migraine

By

OnabotulinumtoxinA was shown to have a better outcome in patients with chronic migraine who start the treatment within 12 months of symptom onset.

Sign Up for Free e-Newsletters